In this video, Dr Abreu, director of the Crohn's and Colitis Center at the University of Miami Miller School of Medicine, previews her talk for the Crohn's & Colitis Congress 2021 on how basic research is being translated to advances in direct care for patients with inflammatory bowel disease.
Dr Brenner discusses her presentation at the Crohn's & Colitis Congress on what data indicate about the risks and disease course of pediatric patients with inflammatory bowel disease during the COVID-19 pandemic.
Marla Dubinsky, MD, and Asher Kornbluth, MD, both from the Icahn School of Medicine at Mount Sinai in New York City, discuss the latest updates on COVID-19 vaccines, recent recommendations from the International Organization of Inflammatory Bowel Diseases, and how they counsel their patients with inflammatory bowel diseases about getting the vaccination.
In this video Dr Knotts, from NYU-Langone Health's Center for Esophageal Health, discusses eosinophilic esophagitis, including its distinction from gastroesophageal reflux disease and how proton pump inhibitors have progressed from use as a diagnostic tool to a treatment for eosinophilic esophagitis.
In this video Dr Catana, with Beth Israel Deaconess Medical Center in Boston, provides highlights of presentations and panel discussions at the American Association for the Study of Liver Diseases meeting on hepatocellular carcinoma.
Dr Long, professor of medicine at the University of North Carolina at Chapel Hill, discusses her presentation at the Advances in Inflammatory Bowel Disease 2020 virtual meeting on how data from both clinical trials and real-world practice can help clinicians make the best choices for therapies for their patients with IBD.
In this video, Michael Chiorean, MD, reviews how JAK inhibitors, IL-12/23 inhibitors, and other, newer therapies are expanding the tools for management of ulcerative colitis.
Dr Kane, professor of medicine at the Mayo Clinic in Rochester, Minnesota, reviews her presentation at the AIBD 2020 virtual meeting on how best to inform and educate patients with inflammatory bowel disease to help ensure good outcomes.
In this video, Dr. Dubinsky, codirector of the Susan and Leonard Feinstein IBD Center at the Icahn School Medicine at Mount Sinai in New York, reviews a panel discussion on therapeutic monitoring of anti-TNF levels in patients with inflammatory bowel disease, presented December 11 at AIBD 2020.
In this video, Dr Kornbluth, of the Icahn School of Medicine at Mount Sinai in New York, reviews his presentation from AIBD 2020 on the importance of careful surveillance for dysplasia and follow-up with patients with inflammatory bowel disease.